Sarcoidosis
Chapter 3:Diseases of the blood and blood-forming organs
ICD-10 D86 is a billable code used to indicate a diagnosis of sarcoidosis.
Sarcoidosis is a systemic granulomatous disease characterized by the formation of non-caseating granulomas in various organs, most commonly the lungs, lymph nodes, skin, and eyes. The etiology of sarcoidosis remains unclear, but it is believed to involve an abnormal immune response to environmental factors in genetically predisposed individuals. Clinically, patients may present with respiratory symptoms such as cough and dyspnea, systemic symptoms like fatigue and fever, and skin manifestations including erythema nodosum or lupus pernio. In some cases, sarcoidosis can lead to significant complications, including pulmonary fibrosis, cardiac involvement, and ocular issues, which can affect the patient's quality of life. Diagnosis is typically made through a combination of clinical evaluation, imaging studies (such as chest X-rays or CT scans), and histological confirmation via biopsy. The management of sarcoidosis may involve observation for asymptomatic cases, corticosteroids for symptomatic patients, and other immunosuppressive agents in more severe cases. Regular monitoring is essential to assess disease progression and treatment response.
Detailed pulmonary function tests, imaging studies, and symptom assessments.
Patients presenting with respiratory symptoms, abnormal chest X-rays, or lung biopsy findings.
Ensure clear documentation of lung involvement and response to treatment.
Comprehensive assessment of systemic symptoms and extra-pulmonary manifestations.
Patients with joint pain, skin lesions, or ocular symptoms associated with sarcoidosis.
Document any multi-organ involvement and treatment plans for systemic manifestations.
Used for obtaining lung biopsy in suspected sarcoidosis cases.
Document indication for bronchoscopy and findings.
Pulmonologists should ensure clear documentation of the procedure and its necessity.
The primary treatment for sarcoidosis is corticosteroids, which help reduce inflammation and manage symptoms. In more severe cases, other immunosuppressive agents may be used.
